Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health In Tech (HIT) Research & Development (2024 - 2025)

Health In Tech has reported Research & Development over the past 2 years, most recently at $213113.0 for Q4 2025.

  • Quarterly results put Research & Development at $213113.0 for Q4 2025, down 91.54% from a year ago — trailing twelve months through Dec 2025 was $2.2 million (down 45.29% YoY), and the annual figure for FY2025 was $1.6 million, down 44.23%.
  • Research & Development for Q4 2025 was $213113.0 at Health In Tech, down from $881562.0 in the prior quarter.
  • Over the last five years, Research & Development for HIT hit a ceiling of $2.5 million in Q4 2024 and a floor of $67278.0 in Q3 2024.